Legal & General Group
DRUG

Legal & General Group’s Bright Minds Biosciences DRUG Stock Holding History

Legal & General Group’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45K Buy
616
+69
+13% +$5.55K ﹤0.01% 2702
2025
Q4 		$43K Buy
547
+34
+7% +$2.27K ﹤0.01% 2767
2025
Q3 		$31K Hold
513
– – ﹤0.01% 2879
2025
Q2 		$13.5K Buy
+513
New +$15.4K ﹤0.01% 3167

Other funds holding DRUG

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Legal & General Group's DRUG Position: Q1 2026 in Review

Legal & General Group increased its Bright Minds Biosciences (DRUG) stake by 13% in Q1 2026, buying an estimated $5.55K and bringing the position to 616 shares worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #2702.

Legal & General Group first reported a position in DRUG in Q2 2025 and has held it in 4 quarters since. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Legal & General Group held 616 shares of Bright Minds Biosciences worth $45K as of Q1 2026.
  • Legal & General Group bought 69 Bright Minds Biosciences shares in Q1 2026, an estimated $5.55K.
  • Bright Minds Biosciences made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2702 holding.
  • Legal & General Group first reported a position in Bright Minds Biosciences in Q2 2025 and has held it in 4 quarters since.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.